首页> 外文OA文献 >Safety and Efficacy of Combination Therapy with Insulin Glargine and Oral Hypoglycaemic Agents Including DPP-4 Inhibitors in Japanese T2DM Patients: ALOHA 2 Study, a Post-Marketing Surveillance for Lantussupamp;reg;/sup

【2h】

Safety and Efficacy of Combination Therapy with Insulin Glargine and Oral Hypoglycaemic Agents Including DPP-4 Inhibitors in Japanese T2DM Patients: ALOHA 2 Study, a Post-Marketing Surveillance for Lantussupamp;reg;/sup

机译：与日本T2DM患者的DPP-4抑制剂包括DPP-4抑制剂的胰岛素冰壶和口服低血糖药物的安全性和有效性：Aloha 2研究，兰花 reg的营销后监测;

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者
Masayuki Kobayashi; Shoko Tsukube; Yukio Ikeda; Yujin Shuto;
展开▼
作者单位

展开▼
年度 2014
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献

1. Safety and Efficacy of Combination Therapy with Insulin Glargine and Oral Hypoglycaemic Agents Including DPP-4 Inhibitors in Japanese T2DM Patients: ALOHA 2 Study, a Post-Marketing Surveillance for Lantus? [J] . Masayuki Kobayashi, Shoko Tsukube, Yukio Ikeda, Journal of Diabetes Mellitus . 2014,第4期

机译：在日本T2DM患者中联合使用甘精胰岛素和口服降血糖药（包括DPP-4抑制剂）联合治疗的安全性和有效性：ALOHA 2研究，Lantus的上市后监测？
2. Effectiveness and safety of basal supported oral therapy with insulin glargine, in Japanese insulin-naive, type 2 diabetes patients, with or without microvascular complications: subanalysis of the observational, non-interventional, 24-week follow-up Add-on Lantus (R) to Oral Hypoglycemic Agents (ALOHA) study [J] . Odawara Masato, Kadowaki Takashi, Naito Yusuke Journal of diabetes and its complications . 2015,第1期

机译：基础胰岛素支持的甘精胰岛素口服治疗在日本无胰岛素的2型糖尿病患者中是否有微血管并发症的有效性和安全性：观察性，非干预性，24周随访附加Lantus（R）的亚分析）进行口服降糖药（ALOHA）研究
3. Incidence and predictors of hypoglycemia in Japanese patients with type 2 diabetes treated by insulin glargine and oral antidiabetic drugs in real-life: ALOHA post-marketing surveillance study sub-analysis [J] . Masato Odawara, Takashi Kadowaki, Yusuke Naito Diabetology and Metabolic Syndrome . 2014,第1期

机译：在现实生活中使用甘精胰岛素和口服降糖药治疗的日本2型糖尿病患者低血糖的发生率和预测因素：ALOHA售后监测研究子分析
4. Efficacy and safety assessment of basal supported oral therapy (BOT) with insulin glargine in a real-life clinical setting stratified by concomitant orally administered antidiabetic agent (OAD) regimens including dipeptidyl peptidase-4 inhibitor (DPP-4i): subanalysis of the ALOHA2 study drug-use surveillance in Japan [O] . Shoko Tsukube, Takashi Kadowaki, Masato Odawara 2016

机译：甘精胰岛素在现实生活中的基础支持口服治疗（BOT）的疗效和安全性评估按口服降糖药（OAD）方案（包括二肽基肽酶-4抑制剂（DPP-4i））进行分层：ALOHA2的亚分析研究日本的毒品使用监视
5. Efficacy and safety assessment of basal supported oral therapy (BOT) with insulin glargine in a real-life clinical setting, stratified by concomitant orally administered antidiabetic agent (OAD) regimens including dipeptidyl peptidase-4 inhibitor (DPP-4i): subanalysis of the ALOHA2 study, drug-use surveillance in Japan [O] . Shoko Tsukube, Takashi Kadowaki, Masato Odawara 2016

机译：基础支持的口服治疗（BOT）在真实临床环境中具有胰岛素甘油的疗效和安全评估，通过伴随口服给药的抗糖尿病（OAD）方案分层，包括二肽基肽酶-4抑制剂（DPP-4i）：Aloha2的细胞分析研究，日本的药用监测

Safety and Efficacy of Combination Therapy with Insulin Glargine and Oral Hypoglycaemic Agents Including DPP-4 Inhibitors in Japanese T2DM Patients: ALOHA 2 Study, a Post-Marketing Surveillance for Lantussupamp;reg;/sup

著录项

相似文献

相关主题

期刊订阅